J3O

propan-2-yl 2-[4-(4-chlorophenyl)carbonylphenoxy]-2-methyl-propanoate

Find entries where: J3O

is present as a standalone ligand in 1 entries

Find related ligands:

Chemical Component Summary
Name	propan-2-yl 2-[4-(4-chlorophenyl)carbonylphenoxy]-2-methyl-propanoate
Identifiers	propan-2-yl 2-[4-(4-chlorophenyl)carbonylphenoxy]-2-methyl-propanoate
Formula	C₂₀ H₂₁ Cl O₄
Molecular Weight	360.831
Type	NON-POLYMER
Isomeric SMILES	CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c2ccc(cc2)Cl
InChI	InChI=1S/C20H21ClO4/c1-13(2)24-19(23)20(3,4)25-17-11-7-15(8-12-17)18(22)14-5-9-16(21)10-6-14/h5-13H,1-4H3
InChIKey	YMTINGFKWWXKFG-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	46
Chiral Atom Count	0
Bond Count	47
Aromatic Bond Count	12

Drug Info: DrugBank

DrugBank ID	DB01039
Name	Fenofibrate
Groups	approved
Description	Fenofibrate is a fibric acid derivative like [clofibrate] and [gemfibrozil].[A185954] Fenofibrate is used to treat primary hypercholesterolemia, mixed dyslipidemia, severe hypertriglyceridemia.[L8588,L8591] Fenofibrate was granted FDA approval on 31 December 1993.[L8585]
Synonyms	FNF Fenofibratum Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate Isopropyl (4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl)propionate Fenofibrato Procetofen 2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester Fenofibrate Finofibrate
Brand Names	Lipidil Micro - Cap 67mg Pravafenix Lipidil Supra Novo-fenofibrate Micronized Aa-feno-super Fenofibrate Fenoglide Lipidil Cap 100mg Aa-feno-micro Nu-feno-micro Pro-feno-super - 100 Riva-fenofibrate Micro PMS-fenofibrate Supra Pro-feno-super - 160 Lipidil Supra 100 mg Tricor Fenofibrate Micro Triglide Novo-fenofibrate Ntp-fenofibrate-S Lofibra Mint-fenofibrate E Cholib Sandoz Fenofibrate S PMS-fenofibrate Micro Fenomax PHL-fenofibrate Supra Ran-fenofibrate S Taro-fenofibrate E Feno-micro-200 Fenofibrate film coated Antara Dom-fenofibrate Micro Ratio-fenofibrate Mc Lipidil Micro Lipidil Ez Lipofen Sandoz Fenofibrate E Mylan-fenofibrate Micro PMS-fenofibrate Dom-fenofibrate Supra Fenofibrate-S Teva-fenofibrate-S PHL-fenofibrate Micro Q-fenofibrate Micro Ava-fenofibrate Micro
Indication	Fenofibrate is indicated as adjunctive therapy to diet to reduce elevated LDL-C, Total-C, Triglycerides, and Apo B, and to increase HDL-C adults with primary hypercholesterolemia or mixed dyslipidemia.[L8588,L8591] Fenofibrate is also indicated to treat adults with severe hypertriglyceridemia.[L8588,L8591]
Categories	Acids, Acyclic Agents Causing Muscle Toxicity Benzene Derivatives Benzophenones BSEP/ABCB11 Substrates Butyrates Cytochrome P-450 CYP2A6 Inhibitors Cytochrome P-450 CYP2A6 Inhibitors (weak) Cytochrome P-450 CYP2C19 Inhibitors Cytochrome P-450 CYP2C19 Inhibitors (weak) Cytochrome P-450 CYP2C8 Inhibitors Cytochrome P-450 CYP2C8 Inhibitors (weak) Cytochrome P-450 CYP2C9 Inhibitors Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A4 Substrates (strength unknown) Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Drugs that are Mainly Renally Excreted Ethers Fatty Acids Fatty Acids, Volatile Fibric Acid Derivatives Fibric Acids Hypolipidemic Agents Hypolipidemic Agents Indicated for Hyperlipidemia Isobutyrates Ketones Lipid Modifying Agents Lipid Modifying Agents, Plain Lipid Regulating Agents Lipids Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia Noxae P-glycoprotein inhibitors Peroxisome Proliferator Receptor alpha Agonist Peroxisome Proliferator-activated Receptor alpha Agonists Phenols Phenyl Ethers Toxic Actions UGT1A9 Substrates
ATC-Code	C10BA03 C10BA12 C10AB05 C10BA09 C10BA04
CAS number	49562-28-9

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Peroxisome proliferator-activated receptor alpha	MVDTESPLCPLSPLEAGDLESPLSEEFLQEMGNIQEISQSIGEDSSGSFG...	unknown	agonist
Nuclear receptor subfamily 1 group I member 2	MEVRPKESWNHADFVHCEDTESVPGKPSVNADEEVGGPQICRVCGDKATG...	unknown	partial agonist
Matrix metalloproteinase-25	MRLRLRLLALLLLLLAPPARAPKPSAQDVSLGVDWLTRYGYLPPPHPAQA...	unknown	inhibitor
UDP-glucuronosyltransferase 1-9	MACTGWTSPLPLCVCLLLTCGFAEAGKLLVVPMDGSHWFTMRSVVEKLIL...	unknown	substrate
Liver carboxylesterase 1	MWLRAFILATLSASAAWGHPSSPPVVDTVHGKVLGKFVSLEGFAQPVAIF...	unknown	substrate
Carbonyl reductase [NADPH] 1	MSSGIHVALVTGGNKGIGLAIVRDLCRLFSGDVVLTARDVTRGQAAVQQL...	unknown	substrate
Cytochrome P450 2C8	MEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDI...	unknown	inhibitor
Cytochrome P450 2C19	MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDV...	unknown	inhibitor
Cytochrome P450 2A6	MLASGMLLVALLVCLTVMVLMSVWQQRKSKGKLPPGPTPLPFIGNYLQLN...	unknown	inhibitor
Aldo-keto reductase family 1 member C1	MDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEATKLAIEAGFRHID...	unknown	substrate
Aldo-keto reductase family 1 member C2	MDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEAVKLAIEAGFHHID...	unknown	substrate
Aldo-keto reductase family 1 member C3	MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHID...	unknown	substrate
Aldose reductase	MASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQ...	unknown	substrate
Cytochrome P450 2C9	MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDI...	unknown	inhibitor
Serum albumin	MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...	unknown	binder
Bile salt export pump	MSDSVILRSIKKFGEENDGFESDKSYNNDKKSRLQDEKKGDGVRVGFFQL...	unknown	substrate
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682